1. Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical. (March 2015) Authors: Orasch, C.; Averbuch, D.; Mikulska, M.; Cordonnier, C.; Livermore, D.M.; Gyssens, I.C.; Klyasova, G.; Engelhard, D.; Kern, W.; Viscoli, C.; Akova, M.; Marchetti, O. Journal: Clinical microbiology and infection Issue: Volume 21:Number 3(2015:Mar.) Page Start: e25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL‐4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Issue 3 (31st January 2013) Authors: Engelhard, D.; Mohty, B.; de la, R.; Cordonnier, C.; Ljungman, P. Journal: Transplant infectious disease Issue: Volume 15:Issue 3(2013) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Re: "Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis" by Horita et al. (June 2018) Authors: Averbuch, D.; Orasch, C.; Mikulska, M.; Livermore, D.M.; Viscoli, C.; Gyssens, I.C.; Kern, W.V.; Klyasova, G.; Marchetti, O.; Engelhard, D.; Akova, M.; Calandra, T.; Cordonnier, C. Journal: Clinical microbiology and infection Issue: Volume 24:Number 6(2018) Page Start: 662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗